mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.02 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.03 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.03 |